| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,550 | 1,610 | 11:24 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.11. | Doseology Sciences Inc (2): Doseology director Kazemi resigns | ||
| 12.09. | Doseology Sciences Inc (2): Doseology appoints Cherry interim CEO; Balaghi departs | ||
| 16.02. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 16.02.2024 | The following instruments on XETRA do have their first trading 16.02.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 16.02.2024
Aktien
1 US22234X1090 Country Garden Holdings... ► Artikel lesen | |
| 15.02. | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA2584841043 Doseology Sciences Inc. 15.02.2024 CA2584842033 Doseology Sciences Inc. 16.02.2024 Tausch 10:1KYG8028L1077 Semper... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Tevogen Bio Inc: Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value | WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio ("Tevogen" or "Tevogen Bio Holdings Inc.") (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically... ► Artikel lesen | |
| Di | Tevogen Bio Holdings reports Q3 results | ||
| Di | Tevogen Bio Inc: Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model | Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for the nine months ended September 30, for 2024 and 2023, respectively.Significantly... ► Artikel lesen | |
| Di | Tevogen Bio Holdings Inc. - 10-Q, Quarterly Report | ||
| 15.11. | Tevogen Bio Holdings Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| DOSEOLOGY SCIENCES INC | 0,156 | 0,00 % |
| TEVOGEN BIO HOLDINGS INC | 1,500 | -3,85 % |
